Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Activities
Net loss	$ (110,173)	$ (58,289)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation, amortization and accretion	10,251	9,201
Impairment expense	75,458	12,825
Shares issuance related to milestone payment	1,425	0
Stock-based compensation expense	5,248	3,574
(Gain) loss from contingent considerations	(1,760)	(4,459)
Amortization of senior debt (premium) discount	(126)	(44)
(Gain) loss on debt extinguishment	(193)	1,569
Inventory write-down	2,186	7,332
Gain on derivative warrant liability	(211)	0
Other noncash adjustments	4	38
Changes in allowance for bad debt	(69)	608
Changes in operating assets and liabilities:
Accounts receivable	6,533	1,544
Inventory	1,299	2,786
Prepaid expenses and other current assets	2,228	157
Accounts payable and other	(7,681)	(3,245)
Accrued liabilities	(13,292)	771
Other operating assets and liabilities, net	50	(332)
Net cash used in operating activities	(28,823)	(25,964)
Investing Activities
Contingent consideration payment	(3,178)	(683)
Cash received from acquisition	0	15,722
Cash payment for business acquisition	0	(15,520)
Cash payment for asset acquisition	0	(2,341)
Other investing activities	(70)	40
Net cash used in investing activities	(3,248)	(2,782)
Financing Activities
Net proceeds from issuance of stock	11,694	40,148
Payment made to fixed payment arrangement	(4,409)	(6,088)
Proceeds from short-term line of credit	152,236	51,206
Payments made on short-term line of credit	(156,357)	(53,979)
Payments made to borrowings	(16,101)	(968)
Proceeds from borrowings	15,000	0
Payment for debt issuance costs	(526)	0
Other financing activities	(7)	(5)
Net cash provided by financing activities	1,530	30,314
Net change in cash, cash equivalents, and restricted cash	(30,541)	1,568
Cash, cash equivalents and restricted cash at beginning of period	49,901	48,333
Cash, cash equivalents and restricted cash at end of period	19,360	49,901
Supplemental cash flow data
Cash paid for interest	3,148	1,249
Non-cash investing and financing activities:
Warrants issued	3,177	1,628
Other noncash investing and financing activities	$ 54
Issuance of common stock for note conversion		1,058
Contingent value rights payout		1,000
Issuance related to acquisition of Neos		53,103
Fair value of non-cash assets acquired		104,322
Fair value of liabilities assumed		88,700
Estimated fair value of replacement equity awards		$ 432